Tofidence Injection
Product Images NDC 78206-201

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tofidence (NDC 78206-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Organon Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Tofidence 01)

A line graph depicting the percentage of ACR20 responders (+/- SE) over time from week 2 to week 24. It compares three treatment groups: placebo + MTX, tocilizumab 8 mg/kg + MTX, and tocilizumab 4 mg/kg + MTX, showing changes in response rates at different visits.*

FDA Label Image

Figure 2 (Tofidence 02)

A forest plot graph showing risk difference and 95% confidence intervals for death rates across four studies (COVACTA, EMPACTA, REMDACTA, RECOVERY) comparing standard of care (SOC) versus tocilizumab plus SOC in patients, with total sample sizes, number of deaths (percentages), and overall combined risk difference displayed along the x-axis ranging from -20 to 20.*

FDA Label Image

Principal Display Panel (200 mg/10 mL Vial Carton)

Packaging label for Tofidence (tocilizumab-bavi) injection, 200 mg/10 mL (20 mg/mL) strength. The label states it is for intravenous infusion after dilution, single-dose vial with instructions to discard unused portions. It includes manufacturing details by Biogen MA Inc., Cambridge, MA, USA, with country of origin China, and storage instructions. Barcode and QR code are present on the label.*

FDA Label Image

Principal Display Panel (400 mg/20 mL Vial Carton)

Packaging label for Tofidence (tocilizumab-bavi) injection, 400 mg/20 mL (20 mg/mL), manufactured by Biogen MA Inc. The label indicates it is for intravenous infusion after dilution, single-dose vial, with instructions to discard unused portion and storage details to refrigerate at 2°C to 8°C, protect from light, and no preservative included. The product is marked Rx Only and includes a barcode and QR codes.*

FDA Label Image

Principal Display Panel (80 mg/4 mL Vial Carton)

Packaging label for Tofidence (tocilizumab-bavi) Injection, 80 mg/4 mL (20 mg/mL) for intravenous infusion after dilution. The label includes instructions to discard unused portions, storage conditions to refrigerate at 2°C to 8°C, and no preservatives. Manufactured by Biogen MA Inc., Cambridge, MA, USA, with the country of origin listed as China. NDC 64406-024-01 is displayed along with barcodes and QR codes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.